Compare Stocks: TVTX vs. ERAS vs. CRSP vs. CGON

Market Snapshot

Current market context for the selected companies.

TVTX

$65.20

Market Cap $6.19B

Sector Healthcare

Industry Biotechnology

Data through 2026-08-24

ERAS

$17.61

Market Cap $6.17B

Sector Healthcare

Industry Biotechnology

Data through 2026-08-24

CRSP

$57.07

Market Cap $5.75B

Sector Healthcare

Industry Biotechnology

Data through 2026-08-24

CGON

$78.24

Market Cap $7.07B

Sector Healthcare

Industry Biotechnology

Data through 2026-08-24

Performance

Absolute returns and relative performance versus SPY.

Metric	TVTX	ERAS	CRSP	CGON
1 Month	+13.7%	-7.8%	+22.6%	+12.9%
1 Month vs SPY	+10.4%	-11.2%	+19.3%	+9.6%
3 Months	+46.7%	+56.7%	+13.3%	+21.8%
3 Months vs SPY	+44.4%	+54.3%	+10.9%	+19.4%
6 Months	+112.2%	+35.3%	+5.7%	+34.2%
6 Months vs SPY	+100.3%	+23.4%	-6.2%	+22.3%
1 Year	+266.5%	+1074.0%	+8.0%	+201.2%
1 Year vs SPY	+246.4%	+1053.9%	-12.1%	+181.0%
2 Years	+624.4%	+540.4%	+14.5%	+116.9%
2 Years vs SPY	+588.0%	+503.9%	-21.9%	+80.4%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric	TVTX	ERAS	CRSP	CGON
Revenue Growth	48.2%	—	1041.4%	—
Earnings Growth	—	—	—	—
Gross Margin	59.2%	0.0%	0.0%	0.0%
Operating Margin	2.3%	0.0%	-1127.6%	-7467.7%
Net Margin	-7.3%	0.0%	0.0%	0.0%
Return on Equity	-236.4%	-78.2%	-26.1%	-26.4%
Return on Assets	-3.7%	-21.4%	-14.2%	-17.7%

Valuation

Common valuation multiples shown side by side.

Metric	TVTX	ERAS	CRSP	CGON
P / E	—	—	—	—
Forward P / E	11.6	-29.5	-17.0	-26.4
P / S	10.3	—	419.6	1,104.6
P / B	60.4	14.7	3.2	6.7
EV / Sales	10.5	—	301.5	940.9
EV / EBIT	449.9	-43.3	-26.7	-12.6
P / FCF	-332.9	-28.4	-26.0	-60.5
FCF Yield	-0.3%	-3.5%	-3.8%	-1.7%

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric	TVTX	ERAS	CRSP	CGON
Free Cash Flow	-$18.25M	-$210.46M	-$215.85M	-$113.71M
Operating Cash Flow	$92.70M	-$98.02M	-$369.58M	-$178.47M
Debt / Equity	2515.7%	12.4%	44.9%	0.9%

Earnings Outlook

Upcoming earnings expectations when available.

Metric	TVTX	ERAS	CRSP	CGON
Next Earnings	2026-10-29	2026-11-11	—	—
EPS Estimate	0.51	-0.11	—	—
Revenue Estimate	195.2M	0	—	—
EPS Growth	-13.2%	+6.9%	—	—
Revenue Growth	+18.4%	+0.0%	—	—
Analyst Coverage	8	8	—	—